These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 14289566)
21. [Hemodynamics and the selection of a method in operations in the intrahepatic form of portal hypertension]. Patsiora MD; Ershov IuA Vestn Khir Im I I Grek; 1973 May; 110(5):9-15. PubMed ID: 4777481 [No Abstract] [Full Text] [Related]
22. [Characteristics of extrahepatic collateral blood flow in patients with cirrhosis of the liver]. Borisova NA; Ryzhkov VK; Gapchenko EM Vestn Khir Im I I Grek; 1988 Apr; 140(4):17-22. PubMed ID: 3420743 [TBL] [Abstract][Full Text] [Related]
24. [Angiographic studies on portal hypertension in childhood]. Zurbriggen S; Fuchs WA; Bettex M Fortschr Geb Rontgenstr Nuklearmed; 1972 Mar; 116(3):318-27. PubMed ID: 4338833 [No Abstract] [Full Text] [Related]
25. [PORTAL HYPERTENSION]. CHIANDUSSI L; GRECO F Omnia Med Ther; 1963; 41():1-81. PubMed ID: 14076801 [No Abstract] [Full Text] [Related]
26. Nebivolol treatment increases splanchnic blood flow and portal pressure in cirrhotic rats via modulation of nitric oxide signalling. Reiberger T; Payer BA; Schwabl P; Hayden H; Horvatits T; Jäger B; Hummel T; Mitterhauser M; Trauner M; Fuhrmann V; Angermayr B; Peck-Radosavljevic M; Liver Int; 2013 Apr; 33(4):561-8. PubMed ID: 23331709 [TBL] [Abstract][Full Text] [Related]
27. Hepatic hemodynamics in idiopathic presinusoidal portal hypertension in Japan. Nakamura S; Kera K; Sasaki K; Takezawa Y Angiology; 1972 Jan; 23(1):7-16. PubMed ID: 5009988 [No Abstract] [Full Text] [Related]
28. 2'-Hydroxyflavanone ameliorates mesenteric angiogenesis and portal-systemic collaterals in rats with liver fibrosis. Hsin IF; Lee JY; Huo TI; Lee FY; Huang HC; Hsu SJ; Wang SS; Ho HL; Lin HC; Lee SD J Gastroenterol Hepatol; 2016 May; 31(5):1045-51. PubMed ID: 26474184 [TBL] [Abstract][Full Text] [Related]
30. Significance of hemodynamic studies in the evaluation of portal hypertension. Smith GW Am Surg; 1973 Jan; 39(1):40-7. PubMed ID: 4686134 [No Abstract] [Full Text] [Related]
31. [Per-rectal scintigraphy of the portal system with pertechnetate TC-99M: effect of propranolol on portosystemic collateral circulation in patients with cirrhosis. Part II]. Bołdys H; Hartleb M; Rudzki K; Nowak A; Nowak S Pol Arch Med Wewn; 1994 Jul; 92(1):19-25. PubMed ID: 7971473 [TBL] [Abstract][Full Text] [Related]
32. Ultrasound in portal hypertension--part 2--and EFSUMB recommendations for the performance and reporting of ultrasound examinations in portal hypertension. Berzigotti A; Piscaglia F; Ultraschall Med; 2012 Feb; 33(1):8-32; quiz 30-1. PubMed ID: 22322479 [No Abstract] [Full Text] [Related]
33. Pathophysiology of portal hypertension. Bosch J; Pizcueta P; Feu F; Fernández M; García-Pagán JC Gastroenterol Clin North Am; 1992 Mar; 21(1):1-14. PubMed ID: 1568769 [TBL] [Abstract][Full Text] [Related]
34. Doppler study of mesenteric, hepatic, and portal circulation in alcoholic cirrhosis: relationship between quantitative Doppler measurements and the severity of portal hypertension and hepatic failure. Taourel P; Blanc P; Dauzat M; Chabre M; Pradel J; Gallix B; Larrey D; Bruel JM Hepatology; 1998 Oct; 28(4):932-6. PubMed ID: 9755228 [TBL] [Abstract][Full Text] [Related]
35. Clinical value of liver and spleen shear wave velocity in predicting the prognosis of patients with portal hypertension. Zhang Y; Mao DF; Zhang MW; Fan XX World J Gastroenterol; 2017 Dec; 23(45):8044-8052. PubMed ID: 29259380 [TBL] [Abstract][Full Text] [Related]
36. [Splenic blood circulation in liver cirrhosis with portal hypertension syndrome]. Bulanov KI Klin Khir; 1998; (8):29-31. PubMed ID: 9866318 [TBL] [Abstract][Full Text] [Related]
37. Dynamic studies on the portal hemodynamics by scintiphotosplenoportography: the visualization of portal venous system using 99mTc. Kashiwagi T; Kamada T; Abe H Gastroenterology; 1974 Oct; 67(4):668-73. PubMed ID: 4472073 [No Abstract] [Full Text] [Related]
38. Green tea polyphenol decreases the severity of portosystemic collaterals and mesenteric angiogenesis in rats with liver cirrhosis. Hsu SJ; Wang SS; Hsin IF; Lee FY; Huang HC; Huo TI; Lee WS; Lin HC; Lee SD Clin Sci (Lond); 2014 May; 126(9):633-44. PubMed ID: 24063570 [TBL] [Abstract][Full Text] [Related]